01.04.2016
- Glaxo SmithKline has announced it will waive patent protection for new medicines in the world’s poorest countries, such as Afghanistan, Rwanda and Cambodia, allowing cheaper...
18.03.2016
- It’s official. Andrew Witty, CEO of Britain’s largest drugmaker, Glaxo SmithKline (GSK), has announced he will retire in March 2017 after nearly a decade at the helm. In a...
16.03.2016
- AstraZeneca shareholders are said to be questioning the £8.4 million pay package awarded to CEO executive Pascal Soriot last year after he successfully deflected a hostile bid from...
01.03.2016
- British drugmaker GlaxoSmithKline is said to have launched a search for a new CEO to replace Andrew Witty, who is now widely expected to step down at the latest by the end of 2017...
05.02.2016
- Glaxo SmithKline CEO Andrew Witty has become the first pharmaceutical or chemical company executive to come out in favor of the UK remaining in the EU, although business leaders in...
26.01.2016
- More than 80 international drug and biotechnology companies have urged governments to work with them to combat the emergence of drug-resistant superbugs, according to a report by...
06.11.2015
- GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
